We found that 10–100 μM NaHS decreased the BAX/BCL-2 ratio, whereas 600–1000 μM NaHS dose-dependently increased the BAX/BCL-2 ratio in HCC cells. The gene discussed is BAX; the disease is hepatocellular carcinoma.